18235022

Source:http://linkedlifedata.com/resource/pubmed/id/18235022

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007634, umls-concept:C0011847, umls-concept:C0014822, umls-concept:C0521390, umls-concept:C0549652, umls-concept:C1554888
pubmed:issue	2
pubmed:dateCreated	2008-1-31
pubmed:abstractText	To explore and evaluate the protective effect of erythropoietin (EPO) on retinal cells of chemically induced diabetic rats after EPO was injected intravitreally at the onset of diabetes.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/R01 EY015281-04, http://linkedlifedata.com/resource/pubmed/grant/R01 EY018343-01
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7703701
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin, http://linkedlifedata.com/resource/pubmed/chemical/Evans Blue, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Erythropoietin, http://linkedlifedata.com/resource/pubmed/chemical/STAT5 Transcription Factor
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0146-0404
pubmed:author	pubmed-author:HaqMM, pubmed-author:HuGuohuG, pubmed-author:JayMM, pubmed-author:JinYingY, pubmed-author:LiWeiyeW, pubmed-author:LuoYanY, pubmed-author:RohJ RJR, pubmed-author:SinclairStephen HSH, pubmed-author:WuYalanY, pubmed-author:XuGuo-TongGT, pubmed-author:YanoffMyronM, pubmed-author:ZhangJingfaJ
pubmed:issnType	Print
pubmed:volume	49
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	732-42
pubmed:dateRevised	2011-1-14
pubmed:meshHeading	pubmed-meshheading:18235022-Animals, pubmed-meshheading:18235022-Apoptosis, pubmed-meshheading:18235022-Blood-Retinal Barrier, pubmed-meshheading:18235022-Blotting, Western, pubmed-meshheading:18235022-Capillary Permeability, pubmed-meshheading:18235022-Diabetes Mellitus, Experimental, pubmed-meshheading:18235022-Diabetic Retinopathy, pubmed-meshheading:18235022-Erythropoietin, pubmed-meshheading:18235022-Evans Blue, pubmed-meshheading:18235022-Immunoenzyme Techniques, pubmed-meshheading:18235022-In Situ Nick-End Labeling, pubmed-meshheading:18235022-Injections, pubmed-meshheading:18235022-Male, pubmed-meshheading:18235022-Mitogen-Activated Protein Kinase 1, pubmed-meshheading:18235022-Mitogen-Activated Protein Kinase 3, pubmed-meshheading:18235022-Neurons, pubmed-meshheading:18235022-Rats, pubmed-meshheading:18235022-Rats, Sprague-Dawley, pubmed-meshheading:18235022-Receptors, Erythropoietin, pubmed-meshheading:18235022-Retinal Vessels, pubmed-meshheading:18235022-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:18235022-STAT5 Transcription Factor, pubmed-meshheading:18235022-Vitreous Body
pubmed:year	2008
pubmed:articleTitle	Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
pubmed:affiliation	Laboratory of Clinical Visual Sciences, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiao Tong University School of Medicine, Shanghai, China.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't